Видео ютуба по тегу Milestone Pharmaceuticals

My Take on Milestone Pharmaceuticals' $75M Royalty Sale
My Take on Milestone Pharmaceuticals' $75M Royalty Sale
Is MIST Stock a Good Buy Now? Watch This Before It's too Late!
Is MIST Stock a Good Buy Now? Watch This Before It's too Late!
MIST Stock Analysis: FDA Approved Cardamyst! (Definitive Buy?)
MIST Stock Analysis: FDA Approved Cardamyst! (Definitive Buy?)
MIST: Cardamyst's Potential to Disrupt the ER Monopoly?
MIST: Cardamyst's Potential to Disrupt the ER Monopoly?
Milestone Pharmaceuticals (MIST): Why Wall Street Is Quietly Getting More Bullish
Milestone Pharmaceuticals (MIST): Why Wall Street Is Quietly Getting More Bullish
Milestone Pharmaceuticals CARDAMYST FDA Approval Call
Milestone Pharmaceuticals CARDAMYST FDA Approval Call
Milestone Pharma Is Now a Commercial Company — Here’s What the Market Is Pricing In
Milestone Pharma Is Now a Commercial Company — Here’s What the Market Is Pricing In
MIST Stock Analysis (Milestone Pharmaceuticals Stock) December 15, 2025
MIST Stock Analysis (Milestone Pharmaceuticals Stock) December 15, 2025
Milestone's CARDAMYST FDA Win: MIST Set to Explode! MIST Stock Analysis
Milestone's CARDAMYST FDA Win: MIST Set to Explode! MIST Stock Analysis
Итоги заседания Milestone Pharmaceuticals по итогам голосования PDUFA (13 декабря 2025 г.)
Итоги заседания Milestone Pharmaceuticals по итогам голосования PDUFA (13 декабря 2025 г.)
Milestone’s Big Moment Is Here — CARDAMYST Launch Imminent! MIST Stock Analysis
Milestone’s Big Moment Is Here — CARDAMYST Launch Imminent! MIST Stock Analysis
FDA Approves CARDAMYST: A Revolutionary Nasal Spray for PSVT Patients
FDA Approves CARDAMYST: A Revolutionary Nasal Spray for PSVT Patients
FDA одобрило CARDAMYST™: первый назальный спрей для самостоятельного применения при пароксизмальн...
FDA одобрило CARDAMYST™: первый назальный спрей для самостоятельного применения при пароксизмальн...
CARDAMYST FDA Approval: Self-Administered Nasal Spray for PSVT — What This Means for You
CARDAMYST FDA Approval: Self-Administered Nasal Spray for PSVT — What This Means for You
FDA Approves CARDAMYST Nasal Spray for PSVT — Milestone’s Self-Administered Breakthrough
FDA Approves CARDAMYST Nasal Spray for PSVT — Milestone’s Self-Administered Breakthrough
FDA одобрило CARDAMYST: революционный назальный спрей для пациентов с пароксизмальной наджелудочк...
FDA одобрило CARDAMYST: революционный назальный спрей для пациентов с пароксизмальной наджелудочк...
Анализ компании Milestone Pharmaceuticals Inc. (MIST) и перспективы препарата Этрипамил.
Анализ компании Milestone Pharmaceuticals Inc. (MIST) и перспективы препарата Этрипамил.
Топ-3 акций малых фармацевтических компаний, за которыми стоит следить в 2026 году!
Топ-3 акций малых фармацевтических компаний, за которыми стоит следить в 2026 году!
NRX Pharma Clears FDA Milestone - Ketafree Could Become First Preservative-Free IV Ketamine
NRX Pharma Clears FDA Milestone - Ketafree Could Become First Preservative-Free IV Ketamine
Обзор Milestone Pharmaceuticals MIST Pre PDUFA 01 декабря 2025 г.
Обзор Milestone Pharmaceuticals MIST Pre PDUFA 01 декабря 2025 г.
Sun Pharma Q2 Earnings: Strong Profit, Global Innovation Milestone | ET Now Business Update
Sun Pharma Q2 Earnings: Strong Profit, Global Innovation Milestone | ET Now Business Update
Trending in Cardiovascular: EU Health Plan, Valve Innovation & More
Trending in Cardiovascular: EU Health Plan, Valve Innovation & More
Trending in Cardiovascular: EU Health Plan, Valve Innovation & More
Trending in Cardiovascular: EU Health Plan, Valve Innovation & More
Pakistan’s Pharmaceutical Industry Hits New Milestone Target - Aaj Pakistan
Pakistan’s Pharmaceutical Industry Hits New Milestone Target - Aaj Pakistan
Is This Small Pharma Stock About to Skyrocket? MIST
Is This Small Pharma Stock About to Skyrocket? MIST